Back

Cardiovascular disease modifies blood pressure response to mandibular advancement therapy versus CPAP in obstructive sleep apnea: a prespecified subgroup analysis of the CRESCENT trial

30 August 2026 (17:00 - 17:12)
Organised by: Logo
Congress Presentation Part of: Sleep apnoea and cardiovascular disease Sleep Apnoea ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Yi Hui Ou

Beth Israel Deaconess Medical Center, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
Prognostic impact of obstructive sleep apnea on major cardiovascular outcomes in patients with atrial fibrillation
Mrs S. Lobo (Singapore, SG)
Abstract Slides
Presentation thumbnail
Synergistic prognostic value of event-aligned heart rate surge and hypoxic burden for cardiovascular mortality in sleep apnoea
Doctor Z. Huang (Beijing, CN)
Abstract Slides
Presentation thumbnail
Sleep parameters derived from smartwatch sphygmomanometer are associated with systolic blood pressure and time in therapeutic range: a large-scale real-world longitudinal study
Doctor Y. Chen (Beijing, CN)
Abstract Slides
Presentation thumbnail
Multidimensional physiological burden of nocturnal respiratory events improves the prediction of cardiovascular mortality in obstructive sleep apnoea
Doctor Z. Huang (Beijing, CN)
Abstract Slides

Access the full session

Session thumbnail
Sleep apnoea and cardiovascular disease
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 17:00 CET
You may be interested in
thumbnail
Congress Presentation
Effect of continuous positive airway pressure therapy in patients with paroxysmal atrial fibrillation and obstructive sleep apnea: A randomized controlled trial
31 August 2020
thumbnail
Congress Presentation
Effect of oral semaglutide on CV outcomes across the vascular disease spectrum, from no vascular disease to polyvascular disease, in high-risk type 2 diabetes
1 September 2025
thumbnail
Congress Presentation
Angiotensin-converting enzyme inhibitors for aortic stenosis: a drug-target mendelian randomisation study
1 September 2025
thumbnail
Congress Presentation
Ambulatory blood pressure measurement : profile and correlation with cardiovascular events in treated hypertensive patients
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources